Insulin Delivery Devices Market Size, Share, Report By 2032

The global insulin delivery devices market size was valued at USD 18.5 billion in 2023 and is projected to surpass around USD 32.07 billion by 2032, at a CAGR of 6.30% from 2023 to 2032.

Regional snapshots

The North American region dominated the market for the insulin delivery devices. It accounted for the largest revenue share of about 37.5% in the year 2021. The increased diabetic population and the availability of technologically advanced devices are the reasons which are leading to a high market growth in North America. About 29 million people in US are affected by diabetes. In terms of revenue the North American region accounts for over 1/3 of the insulin delivery devices market share. Also the prevalence of diabetes is growing in Canada. As an increased number of patient base which is suffering from diabetes and its increasing prevalence across many other nations is boosting the market of insulin delivery devices.

Get the Sample Pages of Report@ https://www.precedenceresearch.com/sample/1802

Insulin delivery devices market is expected to grow fast in the Asia Pacific region during the forecast period. In countries like India and China there is expected to be in highest growth due to the presence of increasing population which is suffering from diabetes.

The Asia Pacific market is expected to secure growth as many global vendors are entering the Asia Pacific market. These companies are providing high end products which contribute to the growth of the insulin delivery devices market. Europe holds a considerable and steady position in the insulin delivery devices market.

Report highlights

On the basis of the product, the insulin pen segment is anticipated to grow well during the forecast period. As is an increasing preference for insulin pen and the awareness about the benefits which are offered by the insulin pens are driving the market growth. As the incident pins use technological advancements and at the same time they are affordable the segment shall grow during the forecast period.
On the basis of the end user, the home care segment is expected to see the largest market growth during the forecast period. There’s any increase stored option of insulin delivery devices in the home care settings. As diabetes is a long term and chronicle condition there’s a pressure in order to reduce the health care expenses. And in order to do so many people are using the devices that could be used in administering the hormone at home. The availability of such devices which are extremely beneficial in managing diabetes shall drive the market growth.
The North American region is expected to have the largest market share in the insulin delivery devices market. As is an increase in the amount of money spent on healthcare and an acceptance of the advanced insulin delivery devices or equipment in the North American region is leading to a growth in this market.

Table of Contents

Report Scope of the Insulin Delivery Devices Market

Report Coverage	Details
Market Size by 2032	USD 32.07 Billion
Growth Rate from 2023 to 2032	CAGR of 6.30%
North America Market Share in 2022	39%
Home Care Segment Market Share in 2022	50%
Base Year	2022
Forecast Period	2023 to 2032
Segments Covered	Type, Application, End User, Distribution Channels, Geography

Insulin Delivery Devices Market dynamics

Drivers

The increasing prevalence of diabetes is that important factor for the growth of the insulin delivery devices. As the diabetes patient population is growing day by day the industry is expected to have a significant growth due to the preference for insulin delivery devices as this happens to be a reliable option and provides patient satisfaction. The number of diabetic patients is expected to grow to 700 million in the coming years which will lead to the growth of the market. The insulin delivery devices market is expected to benefit from the increase in the type 1 diabetes. The type one diabetes requires insulin therapy to survive which is extremely intensive insulin therapy. Type 1 diabetes has being characterized with the body’s inability to produce insulin. The favorable reimbursement policies supported by the government of various nations are that celebrating the growth of the market. As there is an increased health care expenditure related to diabetes in many emerging economies the market for the insulin delivery devices shall grow during the forecast period. The market shall expand further as vessel increasing awareness regarding the insulin delivery devices.

Restraints

In the developing nations the issues which are related to the reuse of pen needles or the infusion sets shall hamper the growth of the market. The reimbursement structure in the developing economies is also expected to hamper the market growth. Insulin happens to be an alternative drug delivery method but challenges the growth of the insulin delivery devices market due to an anxiety of needle in the patients.

Opportunities

Increased research and development activities will prove to be profitable for the growth of the market. Continuous research and development activities are label to provide opportunities for the growth of the market.

Challenges

The high cost of insulin pumps poses a great challenge for the growth of the delivery devices market. In the developing nations although the demand for the insulin delivery devices is good but the high cost of these options happens to be here challenge for the growth of this market. In the developing nations as reimbursement policies are not enough there is out of pocket expenditure in order to purchase the devices. The continuous research and developmental activities in the developed as well as developing nations are proving to be a boon in the insulin delivery devices market. the stringent government regulations across the world are hampering the introduction of new products. The stringent government policies add affecting the market growth as the process to introduce a new product or an innovative product into the market could be lengthy.

Insulin Delivery Devices Market Companies

Novo Nordisk A/S
Wockhardt Ltd.
Medtronic
F. Hoffmann-La Roche, Ltd.
Abbott Laboratories
Sanofi
Eli Lilly and Company
Biocon Ltd.
Ypsomed AG
Becton, Dickinson and Company

Key market developments

In March 2022, Novo Nordisk announced the launch of its smart insulin in the UK. This novel product launch will offer competitive advantage and strengthen its industrial position in the UK region.
Medtronic launched the InPen smart insulin pen that is integrated with real-time Guardian Connect CGM data which offers real-time glucose readings coupled with insulin dose data and makes it easier to make smarter dosing decisions. This product launch assisted the company in driving the sales & revenue generation in insulin delivery devices market.

Segments covered in the report

By Type

Insulin Pumps
- Tubed/Tethered
- Tubeless
Insulin Pens
- Reusable
- Disposable
Insulin Pen needles
- Standard
- Safety
Insulin Jet Injectors
Insulin Syringes
Others

By Application

Type I Diabetes
Type II Diabetes

By End User

Home Care
Hospitals & clinics
Others

By Distribution Channels

Online Sales
Hospital Pharmacies
Retail Pharmacies
Other Clinics

By Geography

North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa